SAPIENCE THERAPEUTICS INC has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are DUCENTIS BIOTHERAPEUTICS LTD, ZYSTOR THERAPEUTICS INC and TCR2 THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Merutka Gene | 12 |
#2 | Rotolo Jimmy Andrew | 9 |
#3 | Kappel Barry Jay | 9 |
#4 | Rotolo Jimmy | 3 |
#5 | Kappel Barry | 3 |
#6 | Jimmy Andrew Rotolo | 1 |
#7 | Barry Jay Kappel | 1 |
#8 | Gallagher Erin E | 1 |
#9 | Gene Merutka | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021007158A1 | Modified bcl9 mimetic peptides | |
WO2019136125A1 | Atf5 peptide variants and uses thereof | |
WO2018152446A2 | Cell-penetrating atf5 polypeptides and uses thereof |